VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
Go back to VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan| (NASDAQ: VRXA) | Delayed: 1.80 -0.06 (3.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.86 | 52 Week High | $ | |||
| Open | $1.89 | 52 Week Low | $ | |||
| Day High | $1.95 | P/E | N/A | |||
| Day Low | $1.78 | EPS | $ | |||
| Volume | 175,300 | |||||

